<DOC>
	<DOCNO>NCT00237510</DOCNO>
	<brief_summary>This study base hypothesis terazosin , blocker alpha-1 receptor , effective reduce excessive sweating cause antidepressant treatment , minimal adverse effect .</brief_summary>
	<brief_title>Pilot Study Terazosin Treatment Antidepressant Induced Excessive Sweating</brief_title>
	<detailed_description>Sweating common bothersome side effect treatment antidepressant . Most antidepressant clearly show cause excessive sweating . It unclear extent excessive sweating cause antidepressant become less go away time . In many instance , continue problem even 6 month antidepressant . There generally accept treatment excessive sweating . This study design study whether terazosin effective reduce antidepressant-induced sweating , whether well-tolerated acceptable patient . In addition , secondary objective study determine time take patient respond terazosin , usual dos need improvement , extent reduction sweat . This information help doctor use terazosin purpose patient , help design study treatment .</detailed_description>
	<mesh_term>Hyperhidrosis</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Terazosin</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<criteria>Clinical diagnosis Depressive disorder ( Diagnostic Statistical Manual Mental Disorders IVTR ) Presence excessive sweat selfreport The excessive sweating start initiation antidepressant , treatment antidepressant interrupt , persist 4 week interruption Treatment antidepressant deem clinically necessary due substantial benefit antidepressant , failure respond tolerate alternative Excessive sweating persist least 4 week prior baseline assessment The excessive sweating rat patient least moderately bothersome . Episodes excessive sweat occur least twice week last 4 week Presence another know disease could potentially cause excessive sweating Failure respond antiadrenergic ( reduce activity sympathetic nervous system ) treatment past Blood pressure le 110 mm Hg systolic screen baseline visit Orthostatic hypotension history assessment screen baseline visit ( defined decrease 10 mm Hg great stand 2 minute ) . Current antihypertensive treatment History significant cardiac disease , include coronary artery disease Current use phosphodiesterase type 5 inhibitor : sildenafil ( Viagraâ„¢ ) , tadalafil ( CialisTM ) , vardenafil ( LevitraTM ) History priapism ( persistent painful erection )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Antidepressant induce excessive sweating</keyword>
</DOC>